Emergency Care for Opioid Use Disorder
Brown University via Independent
After participating in this activity, the learner should be better able to:
- Identify patients who may benefit from MOUD
- Describe the differences in nursing assessment of the patient before and after initiation of buprenorphine
METHOD OF PARTICIPATION AND HOW TO RECEIVE CME CREDIT
Nurses must watch the recorded PowerPoint™ lecture in its entirety. Upon completion, you will have access to a post-test and evaluation within Brown University’s CME learning management system. You will also receive an email reminder with a link to the evaluation.
The test and evaluation must be completed for the enduring session attended and assesses the degree to which the session fulfilled the activity’s nursing learning outcome(s), and whether any bias was present. Nurses are also asked to rate the degree to which they gained knowledge and skills at the activity that they intend to apply in their nursing practice. The goal is that at least 80% of attendees will self-report an intent to apply knowledge acquired in their nursing practice and provide a description of how they intend to do so.
A test score of 80% is required to receive a credit certificate at https://cme-learning.brown.edu
In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council on Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.
The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identified openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.
This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual Faculty Disclosure information may be found in the conference handouts.
Faculty Disclosure/Conflict of Interest
The following speakers and planning committee members* have indicated that they have no relevant financial relationships to disclose:
Collette Onyejekwe, PharmD, RPh*
Elizabeth Samuels, MD, MPH, MHS
Rachel S. Wightman, MD
Siana Wood, RN, BSN
Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.